Normal CA-125 and the risk of progression in ovarian cancer. - Suppr | 超能文献

Normal CA-125 and the risk of progression in ovarian cancer.

作者信息

Markman Maurie

出版信息

J Clin Oncol. 2006 Jul 10;24(20):3310; author reply 3310-1. doi: 10.1200/JCO.2006.06.3255.

DOI:10.1200/JCO.2006.06.3255

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Normal CA-125 and the risk of progression in ovarian cancer.

J Clin Oncol. 2006 Jul 10;24(20):3310; author reply 3310-1. doi: 10.1200/JCO.2006.06.3255.

2

Ovarian thecoma mimicking carcinoma on F-18 FDG PET in a postmenopausal woman with elevated CA-125.一名绝经后女性，CA-125升高，F-18 FDG PET显示卵巢纤维瘤酷似癌。

Clin Nucl Med. 2011 Dec;36(12):1133-4. doi: 10.1097/RLU.0b013e3182335e57.

3

Importance of serial CA125 measurements over an absolute cut-off value for the detection of asymptomatic ovarian cancer in high-risk patients.

Int J Gynaecol Obstet. 2016 May;133(2):239-40. doi: 10.1016/j.ijgo.2015.09.013. Epub 2015 Dec 28.

4

Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.与对比增强CT和肿瘤标志物Ca-125相比，18F-FDG PET/CT在卵巢癌患者再分期中诊断腹膜癌转移的作用。

Rev Esp Med Nucl Imagen Mol. 2014 Jan-Feb;33(1):22-7. doi: 10.1016/j.remn.2013.06.008. Epub 2013 Aug 13.

5

Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes.联合正电子发射断层显像/计算机断层扫描用于检测局限于腹膜后淋巴结的复发性卵巢癌。

Gynecol Oncol. 2005 Nov;99(2):294-300. doi: 10.1016/j.ygyno.2005.06.019. Epub 2005 Jul 26.

6

The influence of CA 125 and CEA levels on the results of (18)F-deoxyglucose positron emission tomography in suspected recurrence of epithelial ovarian cancer.CA 125和癌胚抗原水平对疑似上皮性卵巢癌复发患者（18）F-脱氧葡萄糖正电子发射断层扫描结果的影响。

Strahlenther Onkol. 2004 Aug;180(8):497-501. doi: 10.1007/s00066-004-1208-3.

7

Ovarian cancer.卵巢癌

Radiol Clin North Am. 2007 Jan;45(1):149-66. doi: 10.1016/j.rcl.2006.10.012.

8

Intense FDG uptake of metastatic clear cell carcinoma from the ovary in a uterine leiomyoma.

Clin Nucl Med. 2006 Jul;31(7):429-31. doi: 10.1097/01.rlu.0000223141.38391.62.

9

Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent ovarian carcinoma. Initial report.

J Reprod Med. 1999 Sep;44(9):775-8.

10

Malignant transformation of an ovarian mature cystic teratoma: computed tomography findings.卵巢成熟囊性畸胎瘤的恶性转化：计算机断层扫描结果

Arch Gynecol Obstet. 2005 Apr;271(4):355-7. doi: 10.1007/s00404-004-0676-0. Epub 2004 Nov 18.

引用本文的文献

1

Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG study.高危早期卵巢癌患者的术前和化疗前 CA-125 水平 - NRG/GOG 研究。

Gynecol Oncol. 2024 Feb;181:54-59. doi: 10.1016/j.ygyno.2023.12.009. Epub 2023 Dec 21.

2

Salivary Markers for Periodontal and General Diseases.用于牙周病和全身性疾病的唾液标志物

Dis Markers. 2016;2016:9179632. doi: 10.1155/2016/9179632. Epub 2016 Apr 6.

3

Lights and shadows of the tumoral marker CA-125 in ovarian cancer.肿瘤标志物CA-125在卵巢癌中的利弊

Clin Transl Oncol. 2008 Aug;10(8):449-52. doi: 10.1007/s12094-008-0231-8.